Leveraging global multi-ancestry meta-analysis in the study of idiopathic pulmonary fibrosis genetics

Abstract excerpt

The research of rare and devastating orphan diseases, such as idiopathic pulmonary fibrosis (IPF) has been limited by the rarity of the disease itself. The prognosis is poor—the prevalence of IPF is only approximately four times the incidence, limiting the recruitment of patients to trials and studies of the underlying biology. Global biobanking efforts can dramatically alter the future of IPF research. We...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
• Share to Medical Imaging and Pathology Studies
• Share to Pulmonary Hypertension Research and Treatments